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SUMMARY
The 6 minute walk test (6 MWT) has been shown to provide a clinically useful index
of functional capacity in chronic heart failure. We hypothesized that similar results would
be found in patients who had a recent (ie, within a week) myocardial infarction (MI).
Twenty-five patients (23 males, aged 43 to 72 years) who had undertaken an exercise
stress test without complications underwent 3 consecutive 6 MWTs (1 hour apart). Heart
rate, systolic and diastolic blood pressure, the level of perceived exertion (Borg scale), and
the walking distance were determined. In addition, chest pain was assessed by a 0 to 10
numerical rating scale (NRS) and the ECG was continuously monitored. All subjects were
able to successfully complete the exercise tests without major cardiovascular complica-
tions: mild chest pain (NRS 1 to 3) was found in 3 patients. A Bland-Altman analysis
revealed that the mean bias ± 95% confidence interval of the differences on distance
walked between test 2 - test 1 were substantially higher than test 3 - test 2 differences (18
± 66 m and 6 ± 41 m, respectively). The intraclass correlation coefficients were consis-
tently high for all physiological and sensorial responses at the end of the 6 MWTs (range,
0.75 to 0.95). The 6 MWT is a safe and reproducible measurement of functional capacity
in stable patients after a noncomplicated MI, even when performed within a week of the
event. Therefore, this test might be useful for the evaluation of exercise tolerance in
phases I and II of inpatient cardiovascular rehabilitation programs or to assess functional
responses to selected interventions.  (Int Heart J 2006; 47: 533-540)
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MYOCARDIAL infarction (MI) is a major cause of morbidity and mortality
worldwide.1) Exercise impairment after acute MI has been shown to constitute a
negative prognostic factor,2) being closely related to a faster deterioration in
health status and increased utilization of health care resources.3) The distance
walked in a 6-minute test (6 MWT) is a widely used measurement of exercise
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functional capacity in a number of conditions, such as chronic obstructive pulmo-
nary disease (COPD),4) pulmonary hypertension,5) and chronic renal failure.6) In
clinical cardiology, unfortunately, the test has been largely restricted to the eval-
uation of patients with chronic heart failure (CHF).7-10) Although the American
Thoracic Society guideline for the 6 MWT states that a “recent” (within a month)
MI is an absolute contraindication for the test,11) few data are available to support
this contention. In fact, to the best of our knowledge, no previous study has
looked at the safety, reliability, and repeatability of the 6 MWT in patients recov-
ering from an acute MI.
Therefore, the objective of the present study was to determine whether the 6
MWT would provide a robust index of functional capacity in a group of patients
who had a recent MI (within a week).
METHODS
Patients: Twenty-five inpatients (23 males), aged 43 to 72 years, with a diagno-
sis of myocardial infarction (MI) in the preceding 4 to 7 days (median of 6 days)
participated in this prospective, cross-sectional study. MI was defined by the
presence of a biochemical marker of myocardial necrosis (cardiac troponin T and/
or MB fraction of creatine kinase) in a patient with typical symptoms who also
presented with pathological Q waves and/or elevation or depression of the ST
segment (Table I).1) Treatment for acute MI included percutaneous angioplasty
(1), thrombolysis (2), and clinical therapy only (3). The patients were under stan-
dard medical therapy (including β-blockers) and they were considered to be clin-
Table I. Population Characteristics (n = 25)
Variable Value
Gender (M/F)
Age (years)
Presence of pathological Q waves
Myocardial infarction area
Anterior
Inferior
Anterior-septal
Anterior-lateral
Lateral
Thrombolysis
Previous smoking
Previous myocardial infarction
Arterial systemic hypertension
Diabetes mellitus
Dyslipidemia
Obesity
23/2
54.2 ± 7.9
17 (68%)
6 (24%)
12 (48%)
3 (12%)
1 (4%)
3 (12%)
3 (12%)
13 (52%)
3 (12%)
9 (36%)
2 (8%)
5 (20%)
2 (8%)
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ically stable (Killip level I). All patients had previously undergone an incremental
exercise stress test on a treadmill (modified Bruce) which had been completed
without complications. The exclusion criteria were as follows: (1) musculoskele-
tal, neurological or vascular abnormalities, (2) a disabling psychiatric disorder,
(3) post-MI angina or haemodynamic instability, (4) current or previous complex
ventricular arrhythmia, and (5) left bundle branch block. Before the tests, the pro-
cedures, including the known risks, were described and written, informed consent
(as approved by the Institutional Medical Ethics Committee) was obtained from
all patients.
Six-minute walking tests: The 6 MWT was conducted by a single physiotherapist
under medical supervision according to current standards12) in a 33 meter long
internal corridor. Three tests were performed on the same day, one hour apart.
Participants were instructed to “walk from one end of the corridor to the other at
their own pace, in order to cover as much ground as possible.” Every 30 seconds,
the investigator encouraged the participants with the standardized statements
“You're doing well” or “Keep up the good work”. Participants were allowed to
stop and rest during the test, but were instructed to resume walking as soon as
they were able to do so. During the test, cardiac rhythm was continuously fol-
lowed using a Holter system (Dynamis 3000, Sao Paulo, Brazil) and the heart rate
(HR, bpm) was recorded on a HR counter (Polar Accurex Plus, Kempele, Fin-
land). At the end of the 6 MWTs, the respiratory rate (RR, rpm) was checked and
the systolic and diastolic blood pressures were measured (SBP and DBP in
mmHg, respectively). In addition, participants were shown a Borg perceived
effort scale and asked to “indicate your current degree of effort perception” on a
scale of “6 = nothing at all” to “20 = maximal”.13) They were also asked if they
had experienced any chest pain by using a 0 to 10 numerical rating scale (NRS):
0 = “no pain at all”; 1-3 = “mild pain”; 4-6 = “moderate pain”; 7-9 = “severe
pain”; 10 = “unbearable pain”.14) The distance walked was compared with gen-
der-specific predicted values.15) 
Statistical Analysis: Data are expressed as the mean and standard deviation (SD),
with the exception of Borg scores (median and ranges). The limits of agreement
between the variables at the end of the 6 MWTs were investigated by plotting the
individual differences against their means (Bland-Altman analysis). Heterosce-
dasticity was examined by plotting the absolute differences against the individual
means and calculating the Spearman's correlation coefficient.16) If the correlation
was close to zero, the mean bias and the 95% limits of agreement were calculated
as mean ± 1.96 SD of the between-estimate differences. In addition, the intraclass
correlation coefficients (ICC) were calculated: an ICC ≥ above 0.75 was indica-
tive of a high intratest repeatability.17) 
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RESULTS
All patients were able to successfully complete the proposed tests. There
were no clinically significant changes on the ST-segment or complex ventricular
arrhythmias. Isolated ectopic ventricular beats (EVBs) were found in 3 patients in
the 1st and 2nd tests, but only 1 patient showed EVBs in the 3rd test. Three other
patients presented with mild chest pain (NRS = 1 to 3), which was reproducible
in 2.
Table II. Responses to the Three Consecutive 6 MWTs (n = 25)
Variable 1st test 2nd test 3rd test
Distance walked (m)
Distance walked (% predicted)
Heart rate (bpm)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Double product
Respiratory rate (rpm)
Perceived exertion (Borg score)
521 ± 64
89.7 ± 13.7
96 ± 12
130 ± 21
78 ± 11
1262 ± 2884
22 ± 4
12 (7 - 17)
539 ± 70
94.3 ± 14.1
97 ± 14
127 ± 23
75 ± 12
1256 ± 3445
22 ± 4
13 (7 - 17)
545 ± 70
94.5 ± 14.1
98 ± 14
130 ± 22
76 ± 12
1288 ± 3288
22 ± 4
13 (7 - 17)
Values are expressed as the mean ± SD (with the exception of the Borg score: 
median and range)
Figure. Bland-Altman plot of the between-test differences in the distance walked in 6 minutes (6
MWT) as a function of their means. Note that the mean bias (95% confidence interval) was narrower for
the differences between the 3rd and 2nd tests (8 ± 41 m) than the 2nd to 1st test differences (18 ± 66 m).
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The mean distance walked in all tests was close to the predicted value for a
normal, elderly population, however, the values were slightly lower on the 1st test
(Table II).15) In fact, the Bland-Altman analysis showed that the distance walked
increased on the 2nd as compared to the 1st trial, but remained stable on the 3rd test.
Therefore, the mean bias ± 95% confidence interval of the 3rd-2nd and 2nd-1st test
differences were 6 ± 41 and 18 ± 66 m, respectively (Figure). In addition, high
ICCs were observed (Table III).
As shown in Table II, the physiological and perceptual responses to the 6
MWTs were also highly reproducible. After certification of data homocedasticity
(see Data Analysis), Bland-Altman analysis revealed that the between-test limits
of agreement (mean bias ± 95% confidence interval) for the main variables were
larger for the 2nd-1st test than the 3rd-2nd test differences: HR = 1 ± 10 versus 1 ± 8
bpm; SBP = -3 ± 19 versus 3 ± 13 mmHg; DBP = 1 ± 12 versus -3 ± 10 mmHg;
RR = 1 ± 5 versus 1 ± 3 rpm; and double product = -63 ± 2708 versus 323 ± 1981
bpm.mmHg. Similar to the walking distance, the lower limit of the 95% confi-
dence intervals was ≥ 0.75 in all cases (Table III).
DISCUSSION
The findings of this study have demonstrated that a simple and widely-used
measurement of functional capacity (6 MWT) is a safe and reproducible proce-
dure in patients who had a noncomplicated MI within a week of the tests. The
tests, however, should be performed on duplicate to enhance their accuracy. This
is the first study to look at the clinical reliability of the 6 MWT in this patient pop-
ulation. These data are of particular relevance since the evaluation of patient
functional capacity may provide important information to assess a prognosis and
response to therapy, as well as to guide exercise training prescription.18-21) 
The 6 MWT is a field exercise test which has gained popularity in the past 2
decades. Its metabolic, ventilatory, and cardiovascular demands are consistent
Table III. Intraclass Correlation Coefficients (ICC) for Selected Vari-
ables of the 6 MWT
Variable ICC 95% Confidence interval
Distance walked (m)
Heart rate (bpm)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Double product
Respiratory rate (rpm)
Perceived exertion (Borg score)
0.879
0.928
0.926
0.880
0.910
0.880
0.934
0.785
0.868
0.865
0.786
0.790
0.787
0.879
0.939
0.964
0.963
0.940
0.935
0.940
0.968
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with a submaximal test, at least in patients with COPD and CHF.4,11,12,21) The
American Heart Association recommends that a maximum effort test should be
avoided within 2 weeks after an acute myocardial infarction.22) Our data suggest
that this was the case in the present study: HR during the 6 MWT, for instance,
averaged 59 ± 7% of the maximal predicted by age. In this context, the lack of
studies involving the 6 MWT in MI patients is somewhat surprising: measures of
submaximal exercise capacity have been formally recommended before hospital
discharge after acute MI.18) In the present study, all patients were able to success-
fully complete the tests and the mean distance walked was close to the value pre-
dicted from healthy subjects (Table II).15) These data suggest that our patients
exercised at relatively high metabolic demands - even after a recent MI. Future
studies are needed to evaluate whether the distance walked or the ability to com-
plete the 6 MWT provides a useful prognostic index in these patients.
Timed-walk tests were initially used in patients with chronic lung diseases
who were unable to perform a formal exercise test due to extreme breathless-
ness.4) In CHF, such tests have been widely applied to assess the responses to
pharmacological interventions and as a useful prognostic indicator.18-21) These
tests possess a number of advantages such as their simplicity, safety, and negligi-
ble cost. Although the 6 MWT correlated moderately well with peak VO2, it
seems to be more adequate at providing an index of the ability of a patient to carry
on their daily life activities.
The reproducibility of timed-walk tests is thought to be generally good, with
intrasubject coefficients of variation averaging < 10%.7,12) In fact, we did find a
high ICC for the distance walked (0.879), which is consistent with the values
described by others in CHF (0.80-0.91).7-10) However, we found a clear learning
effect from the 1st to the 2nd test with a much narrower variation between the 2nd
and 3rd tests (Figure). The differences were of practical relevance since the 95%
confidence interval of the 2nd-1st test differences was higher than 50 m - a cutoff
proposed by the American Thoracic Society as clinically relevant.11) Our data,
therefore, indicate that 2 consecutive 6 MWTs should be performed in this patient
population and the distance walked on the 2nd trial better reflects the true mea-
surement. In addition to the distance walked, we also showed that the repeatabil-
ity of some easily obtained measures of physiological and sensorial stresses was
also excellent.
Study limitations: This study involved a relatively small number of patients (n =
25), therefore, it cannot be ruled out that a lower degree of repeatability may be
found if a larger and more heterogeneous population had been evaluated. This is
especially true if we consider that all patients were clinically stable after experi-
encing a noncomplicated MI; in addition, the patients had previously undergone
an event-free incremental treadmill test. Consequently, the pretest probability of
•
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a serious adverse event was quite low in this selected population. Future studies
should determine whether our results are also applicable to a more severe popu-
lation, especially those patients with a worse health status. In addition, although
our data are encouraging, it remains to be determined whether the 6 MWT can be
a substitute for the traditional, but more demanding, tests of functional capacity
in assessing the prognosis and responses to therapy after MI.
Conclusions: The 6 MWT, when performed in duplicate, provided a safe, reliable
and reproducible measurement of functional capacity in patients with stable, non-
complicated myocardial infarction, even when performed within a week of the
event. The clinical usefulness of the test in assessing the prognosis and long-term
response to therapy in this patient population remains to be established. The 6
MWT might prove to be useful for the evaluation of exercise tolerance in phases
I and II of inpatient cardiovascular rehabilitation programs or to assess functional
responses to selected interventions early after the acute event.
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